Study guide
4.4 Hepatobiliary Disease, Cirrhosis & Acute Pancreatitis
Professional and Linguistic Assessments Board Part 1 PLAB 1
Track your progress as you read
Finished sections get a check mark.
1 Introduction
About the PLAB 1 Exam
2 Chapter 1: Acute Medicine, Resuscitation & Clinical Emergencies
1.1 The ABCDE Approach, Adult Resuscitation & Shock 1.2 Sepsis, Sepsis Six Protocol & Septic Shock 1.3 Anaphylaxis & Acute Airway Emergencies 1.4 Clinical Toxicology & Acute Poisoning 1.5 Major Trauma, Head Injury, Burns & Environmental Emergencies
3 Chapter 2: Cardiovascular Medicine & Vascular Disorders
2.1 Acute Coronary Syndromes (STEMI & NSTEMI/Unstable Angina) 2.2 Heart Failure & Cardiogenic Shock 2.3 Cardiac Arrhythmias & Syncope 2.4 Hypertension, Valvular Heart Disease & Aortic Emergencies 2.5 Infective Endocarditis, Pericardial Disease, Myocarditis & Cardiomyopathies 2.6 Peripheral Arterial Disease, Aortic Aneurysm & Venous Disease
4 Chapter 3: Respiratory Medicine
3.1 Asthma: Diagnostic Criteria, Chronic Stepping & Acute Exacerbations 3.2 COPD: Staging, Long-Term Management & Acute Exacerbations 3.3 Pneumonia & Lower Respiratory Tract Infections 3.4 Venous Thromboembolism, Pleural Disease & Pneumothorax 3.5 Lung Cancer, Interstitial & Suppurative Lung Disease, Sleep Apnoea & Respiratory Failure
5 Chapter 4: Gastroenterology, Hepatobiliary & General Surgery
4.1 Upper Gastrointestinal Bleeding & Dyspepsia 4.2 Lower Gastrointestinal Bleeding, IBD & Colorectal Malignancy 4.3 Acute Abdomen, Bowel Obstruction & Perforation 4.4 Hepatobiliary Disease, Cirrhosis & Acute Pancreatitis 4.5 Functional, Malabsorptive & Infective Bowel Disorders, Anorectal Disease, Hernias & MASLD
6 Chapter 5: Renal Medicine, Urology & Fluid/Electrolyte Balance
5.1 Acute Kidney Injury & KDIGO Staging 5.2 Chronic Kidney Disease & Glomerular Disorders 5.3 Electrolyte Emergencies: Potassium, Sodium & Calcium 5.4 Urology: Urinary Tract Infections, Renal Colic & Urinary Retention 5.5 Urological Cancers, Prostate Disease & Scrotal Emergencies
7 Chapter 6: Endocrinology & Metabolic Medicine
6.1 Diabetes Mellitus: Diagnostic Criteria & Chronic Management 6.2 Diabetic Emergencies: DKA & Hyperosmolar Hyperglycaemic State 6.3 Thyroid Disorders: Hypothyroidism, Thyrotoxicosis & Thyroid Storm 6.4 Adrenal & Pituitary Disorders: Addisonian Crisis & Pituitary Disease
8 Chapter 7: Neurology & Neurosciences
7.1 Acute Stroke, TIA & Intracranial Haemorrhage 7.2 Acute & Chronic Headaches, Giant Cell Arteritis & CNS Infections 7.3 Seizures, Status Epilepticus & Epilepsy Management 7.4 Neuromuscular Disorders & Movement Disorders 7.5 Raised Intracranial Pressure, Brain Tumours, Cranial Nerve Lesions & Spinal Cord Disorders
9 Chapter 8: Psychiatry & Mental Health
8.1 Affective Disorders: Depression, Bipolar Disorder & Suicide Risk Assessment 8.2 Psychosis, Schizophrenia & Acute Agitation 8.3 Cognitive Disorders, Substance Misuse & the Mental Health Act 8.4 Anxiety Disorders, OCD, PTSD, Eating Disorders, Personality Disorders & Somatic Presentations 8.5 Perinatal, Child & Adolescent and Neurodevelopmental Mental Health
10 Chapter 9: Obstetrics, Gynaecology & Sexual Health
9.1 Early Pregnancy: Miscarriage & Ectopic Pregnancy 9.2 Antenatal & Peripartum Emergencies: Pre-Eclampsia & Haemorrhage 9.3 Common Gynaecological Presentations & Gynaecological Oncology 9.4 Contraception, Emergency Contraception & Sexually Transmitted Infections 9.5 Routine Antenatal Care, Labour & Obstetric Emergencies 9.6 Menopause & HRT, Subfertility, Prolapse & Urinary Incontinence
11 Chapter 10: Paediatrics & Child Health
10.1 The Febrile Child, Sepsis & Meningococcal Disease 10.2 Paediatric Respiratory Distress: Croup, Bronchiolitis & Wheeze 10.3 Paediatric Abdominal Emergencies, Dehydration & Neonatal Jaundice 10.4 Child Safeguarding, Non-Accidental Injury & Developmental Milestones 10.5 Neonatology & Congenital Heart Disease 10.6 Paediatric Orthopaedics, Growth, Childhood Cancer & Common Chronic Problems
12 Chapter 11: Musculoskeletal Medicine & Rheumatology
11.1 Inflammatory Arthropathies & Connective Tissue Diseases 11.2 Crystal Arthropathies (Gout & Pseudogout) & Septic Arthritis 11.3 Osteoporosis, Common Fractures & Orthopaedic Emergencies 11.4 Osteoarthritis, Low Back Pain, Polymyalgia Rheumatica, Fibromyalgia & Soft Tissue Disorders
13 Chapter 12: Dermatology, ENT & Ophthalmology
12.1 Common Dermatoses & Dermatological Emergencies 12.2 ENT Presentations: Infections, Epistaxis, Vertigo, Hearing Loss & Head and Neck Lumps 12.3 The Acute Red Eye: Glaucoma, Uveitis & Keratitis 12.4 Sudden & Gradual Vision Loss, Retinal Disorders & the Visual Pathway 12.5 Skin Infections, Infestations, Childhood Rashes & Skin Cancer
14 Chapter 13: Haematology, Oncology & Palliative Care
13.1 Anaemias & Blood Transfusion Medicine 13.2 Haematological Malignancies: Leukaemias, Lymphomas & Myeloma 13.3 Haemostasis, Coagulation Disorders & Anticoagulant Reversal 13.4 Oncological Emergencies & Palliative Symptom Management 13.5 Breast Disease, Cancer Screening & Suspected Cancer Referral
15 Chapter 14: Perioperative Care, Safe Prescribing & Clinical Pharmacology
14.1 Preoperative Assessment & Perioperative Medication Management 14.2 Postoperative Complications & Fluid Therapy 14.3 High-Risk Medications & Therapeutic Drug Monitoring 14.4 Safe Prescribing Principles & Antimicrobial Stewardship
16 Chapter 15: Medical Ethics, Law & UK Clinical Practice
15.1 GMC Good Medical Practice, Professionalism, Teamwork & Quality Improvement 15.2 Consent, Capacity & the Mental Capacity Act 2005 15.3 Confidentiality, Statutory Reporting & DVLA Regulations 15.4 End-of-Life Decisions, DNACPR, Organ Donation, Adult Safeguarding & Domestic Abuse
17 Chapter 16: Infectious Diseases, Travel Medicine & Infection Prevention
16.1 Tuberculosis, HIV, Hepatitis B & C and Needlestick Injuries 16.2 Fever in the Returning Traveller, Zoonoses, Notifiable Diseases & Infection Prevention
18 Chapter 17: Older Adults, Population Health, Genetics & Clinical Imaging
17.1 Frailty, Falls, Polypharmacy, Continence & Pressure Ulcers 17.2 Medical Statistics, Diagnostic Tests & Critical Appraisal 17.3 Public Health, Screening Principles, Health Inequalities & Health Promotion 17.4 Genetics, Genomics & Pharmacogenomics 17.5 Clinical Imaging: Choosing Tests, Radiation Safety & Interpreting X-rays
4.4 Hepatobiliary Disease, Cirrhosis & Acute Pancreatitis
Key Takeaways Explain This Topic AI
Jaundice differential is classified biochemically: pre-hepatic (isolated unconjugated bilirubin, normal LFTs), hepatic (mixed bilirubin, elevated ALT/AST > ALP), and post-hepatic/obstructive (conjugated bilirubin, pale stools, dark urine, marked ALP/GGT elevation).
Acute cholecystitis presents with continuous RUQ pain, fever, leukocytosis, and positive Murphy's sign, managed with IV antibiotics and laparoscopic cholecystectomy within 1 week of admission.
Ascending cholangitis presents with Charcot's triad (RUQ pain, jaundice, fever/rigors) or Reynolds' pentad (adding shock and confusion); emergency management requires IV resuscitation, broad-spectrum antibiotics, and urgent ERCP decompression.
Cirrhosis complications require specific interventions: spontaneous bacterial peritonitis (ascitic neutrophils >250 cells/mm3) warrants IV cefotaxime and albumin; hepatic encephalopathy is managed with lactulose and rifaximin; SAAG ≥11 g/L confirms portal hypertension.
Acute pancreatitis is diagnosed by ≥2 of: typical epigastric pain radiating to back, serum lipase/amylase ≥3x upper limit, or imaging findings; a Glasgow-Imrie score ≥3 measured within 48h indicates severe pancreatitis requiring HDU/ICU escalation.
Last updated: October 2026
Hepatobiliary Disease, Cirrhosis & Acute Pancreatitis
Hepatobiliary and pancreatic conditions constitute a major segment of acute medical admissions in the United Kingdom. Rapid differentiation between medical and surgical jaundice, prompt identification of biliary sepsis, and systematic severity stratification of acute pancreatitis are essential to prevent catastrophic deterioration.
1. Differential Diagnosis of Jaundice
Jaundice (icterus) is the yellow pigmentation of sclerae, skin, and mucous membranes caused by hyperbilirubinaemia (clinically detectable when serum total bilirubin exceeds >35–50 umol/L ; normal <21 umol/L). Pathophysiological classification depends on bilirubin fractionation and associated liver function test (LFT) derangements.
Category Predominant Bilirubin Biochemical Pattern Urine & Stool Features Primary Clinical Aetiologies
Pre-Hepatic (Haemolytic) Unconjugated (Indirect) Normal ALT, AST, ALP, GGT. Raised serum LDH, reticulocytosis, reduced serum haptoglobin. Normal urine colour (unconjugated bilirubin is water-insoluble and cannot pass the glomerular filter); dark / normal stools (excess stercobilin). • Intravascular/extravascular haemolysis (G6PD deficiency, autoimmune haemolytic anaemia, sickle cell disease, hereditary spherocytosis); • Gilbert's Syndrome: Benign familial deficiency of UDP-glucuronosyltransferase; intermittent mild unconjugated hyperbilirubinaemia triggered by fasting, dehydration, or intercurrent illness; normal LFTs and normal haemoglobin.
Hepatic (Hepatocellular) Mixed (Unconjugated & Conjugated) Predominant elevation of ALT and AST (often >500–1000 IU/L in acute injury). Mild/moderate ALP rise. AST:ALT ratio >2 suggests alcoholic hepatitis. Dark urine (conjugated fraction excreted); normal or pale stools. • Acute viral hepatitis (A, B, C, E); • Paracetamol toxicity (severe hepatocellular necrosis, massive ALT >3000 IU/L); • Autoimmune hepatitis, Wilson's disease, alcoholic hepatitis, decompensated cirrhosis
Post-Hepatic (Obstructive / Cholestatic) Conjugated (Direct) Marked elevation of ALP and GGT (>3x upper reference limit). Mild/moderate ALT/AST elevation. Prolonged PT/INR correctable with parenteral Vitamin K. Dark urine (water-soluble conjugated bilirubin filtered into urine); pale, clay-coloured stools (absence of stercobilin in bowel lumen); intractable pruritus (skin deposition of bile salts). • Choledocholithiasis (gallstone in common bile duct); • Pancreatic Head Carcinoma (Courvoisier's law: painless jaundice + palpable non-tender gallbladder); • Cholangiocarcinoma, ampullary tumours, benign biliary strictures, primary biliary cholangitis (PBC)
Loading diagram... Jaundice Diagnostic & Liver Function Pattern Pathway
2. Gallstone Disease Spectrum (Cholelithiasis)
Gallstones affect ~15% of the adult UK population. Pathophysiology involves supersaturation of bile with cholesterol (80%) or bilirubin (pigment stones in haemolysis). The clinical spectrum spans asymptomatic carriage to life-threatening ascending cholangitis: [ Gallstone Disease Spectrum ]
- │
- ┌───────────────────────────────┼───────────────────────────────┐
- ▼ ▼ ▼
- [ Biliary Colic ] [ Acute Cholecystitis ] [ Ascending Cholangitis ]
- Transient cystic duct • Persistent cystic duct • Choledocholithiasis +
- obstruction obstruction + infection bacterial superinfection
- Colicky RUQ pain < 6h • Constant RUQ pain > 6h • Charcot's Triad:
- Provoked by fatty foods • Fever, leukocytosis, CRP - RUQ pain
- Normal LFTs, no fever • Positive Murphy's Sign - Jaundice
- Elective laparoscopic • Thickened wall (>3 mm) - Fever / Rigors
- cholecystectomy • Laparoscopic Cholecystectomy • Reynolds' Pentad (add Shock & Confusion)
- within 1 week of admission • Emergency Resuscitation + IV Abx
- Urgent ERCP Biliary Decompression
- Acute Cholecystitis
Clinical Presentation: Persistent, severe right upper quadrant (RUQ) or epigastric pain lasting >6 hours, radiating to the right infrascapular area (via phrenic nerve C3–C5 irritation). Accompanied by fever, anorexia, nausea, and vomiting.
Physical Examination: Positive Murphy's Sign (palpation of the RUQ while the patient takes a deep breath produces sudden arrest of inspiration due to sharp pain when the inflamed gallbladder descends onto the examining hand).
Diagnostic Imaging: Transabdominal Ultrasound is the initial investigation of choice; demonstrates gallstones, gallbladder wall thickening >3 mm , pericholecystic fluid, and sonographic Murphy's sign.
Management: Nil-by-mouth, IV balanced crystalloids, adequate analgesia (NSAIDs or opioids), intravenous broad-spectrum antibiotics (e.g. IV co-amoxiclav), and early laparoscopic cholecystectomy within 1 week of presentation (ideally within 72 hours) . NICE guidelines confirm that early index-admission surgery significantly reduces recurrent admissions and total hospital stay compared to delayed elective surgery.
Ascending Cholangitis
Ascending cholangitis occurs when choledocholithiasis or a biliary stricture causes complete biliary outflow obstruction, leading to bacterial stasis and purulent infection ascending into the intrahepatic biliary tree (predominantly Escherichia coli , Klebsiella pneumoniae , and Enterococcus species).
Charcot's Triad:
- Right Upper Quadrant Pain
- Jaundice
- High Fever with Shaking Rigors / Chills
Reynolds' Pentad: Charcot's triad PLUS hypotension (septic shock) and altered mental status (confusion/delirium) . Signifies acute toxic suppurative cholangitis with catastrophic mortality.
Emergency Management Protocol:
Immediate aggressive fluid resuscitation according to Sepsis Six protocols.
Intravenous broad-spectrum antimicrobials with high biliary penetration (e.g. IV piperacillin-tazobactam or cefotaxime + metronidazole).
Urgent biliary decompression via Endoscopic Retrograde Cholangiopancreatography (ERCP) within 24 to 48 hours (or emergency ERCP within <12 hours if the patient is in septic shock or failing conservative medical therapy). Percutaneous transhepatic cholangiography (PTC) is the alternative if ERCP is anatomically unachievable.
3. Cirrhosis & Complications of End-Stage Liver Disease
Cirrhosis represents end-stage hepatic fibrosis characterized by distortion of hepatic parenchymal architecture into regenerative nodules.
Ascites & Diagnostic Paracentesis
Diagnostic paracentesis is mandatory in all patients presenting with new-onset ascites or hospital admission for decompensated cirrhosis.
SAAG = Serum Albumin − Ascitic Fluid Albumin \text{SAAG} = \text{Serum Albumin} - \text{Ascitic Fluid Albumin} SAAG = Serum Albumin − Ascitic Fluid Albumin
High SAAG (≥ 11 g/L): Diagnostic of portal hypertension (transudative fluid driven by elevated hydrostatic pressure: cirrhosis, congestive cardiac failure, Budd-Chiari syndrome, constrictive pericarditis).
Low SAAG (< 11 g/L): Excludes portal hypertension; indicates peritoneal disease or altered permeability (peritoneal carcinomatosis, tuberculous peritonitis, nephrotic syndrome, pancreatitis).
Medical Management: Dietary sodium restriction (<2 g/day / 80 mmol/day), aldosterone antagonist spironolactone (100–400 mg once daily) , and loop diuretic furosemide (40–160 mg daily) . Large-volume paracentesis (LVP) for tense refractory ascites must be accompanied by intravenous human albumin solution (HAS, 20% solution) infusion at a dose of 8 g of albumin per litre of ascites removed over 5 litres , preventing post-paracentesis circulatory dysfunction.
Spontaneous Bacterial Peritonitis (SBP)
SBP is spontaneous infection of ascitic fluid without an identifiable surgically treatable source of intra-abdominal infection. It occurs in up to 20% of hospitalized cirrhotics with ascites.
Diagnostic Hallmark: Ascitic fluid neutrophil (polymorphonuclear leukocyte [PMN]) count > 250 cells/mm³ (or >0.25 × 10⁹/L). Neutrophil count is calculated by multiplying total ascitic WCC by the percentage of neutrophils.
Clinical Presentation: Can be remarkably insidious; low-grade fever, mild abdominal discomfort, worsening encephalopathy, or unexplained acute kidney injury.
Treatment: Immediate empirical intravenous cefotaxime 2 g TDS (or ceftriaxone) PLUS intravenous human albumin solution (1.5 g/kg at diagnosis, followed by 1.0 g/kg on Day 3; albumin significantly reduces the incidence of hepatorenal syndrome from 30% to 10% and cuts mortality by two-thirds).
Lifelong Secondary Prophylaxis: Following recovery, initiate lifelong oral ciprofloxacin (500 mg daily) or rifaximin to prevent recurrent SBP.
Hepatic Encephalopathy (HE)
Hepatic encephalopathy is a reversible neurocognitive syndrome resulting from failure of the cirrhotic liver to detoxify gut-derived nitrogenous waste products (primarily ammonia), compounded by portosystemic shunting.
Clinical Features: Early reversal of sleep-wake cycle, apathy, personality change, progressing to confusion, lethargy, asterixis (bilateral flapping tremor) , and coma.
Precipitating Triggers: Constipation, infection (SBP, UTI), upper GI bleeding, electrolyte imbalance (hypokalaemia, hyponatraemia), dehydration (over-diuresis), and sedative medications.
First-Line Pharmacological Management:
Lactulose: Synthetic disaccharide titrated to produce 2 to 3 soft bowel movements per day . It is fermented by colonic bacteria into lactic and acetic acids; luminal acidification converts diffusible ammonia ( N H 3 NH_3 N H 3 ) into non-absorbable ammonium ions ( N H 4 + NH_4^+ N H 4 + ), trapping it in the bowel lumen for excretion.
Rifaximin: Non-absorbable oral antibiotic (550 mg BD) added to lactulose for secondary prevention or refractory cases; suppresses ammonia-producing colonic bacteria.
4. Acute Pancreatitis: Aetiology, Diagnosis & Severity Stratification
Acute pancreatitis is acute inflammatory necrosis of the pancreatic parenchyma induced by premature intracellular activation of digestive zymogens (trypsinogen to trypsin).
- Aetiology: "I GET SMASHED"
- I – Idiopathic
- G – Gallstones (#1 cause in UK, ~45–50%)
- E – Ethanol (#2 cause in UK, ~30–35%)
- T – Trauma (blunt abdominal trauma, handle-bar injury in children)
- S – Steroids
- M – Mumps and other viruses (Coxsackie B, CMV, Epstein-Barr)
- A – Autoimmune pancreatitis (IgG4-associated pancreatitis)
- S – Scorpion venom ( Tityus trinitatis )
- H – Hyperlipidaemia (serum triglycerides >11 mmol/L) / Hypercalcaemia (hyperparathyroidism)
- E – ERCP (post-procedure pancreatitis in 3–5%)
- D – Drugs (Azathioprine, 6-mercaptopurine, thiazide diuretics, sodium valproate, didanosine)
- Diagnostic Criteria (The Atlanta Consensus)
Diagnosis requires at least 2 of the following 3 criteria :
Severe, acute-onset, persistent epigastric pain radiating directly through to the back , often relieved by leaning forward.
Serum amylase or lipase ≥ 3 times the upper limit of normal . (Serum lipase is more sensitive and specific than amylase; lipase remains elevated for 8–14 days, whereas amylase may normalize within 48–72 hours).
Characteristic cross-sectional imaging features of acute pancreatitis on contrast-enhanced CT, MRI, or transabdominal ultrasound.
Note
Diagnostic Pearl: If classical epigastric pain and lipase ≥3x normal are present, contrast-enhanced CT is not required upon admission. Early CT (<72 hours) often underestimates pancreatic necrosis and is indicated only if diagnostic uncertainty exists or if the patient deteriorates after 72 hours.
Severity Stratification: The Modified Glasgow-Imrie Criteria
Assessed within the first 48 hours of hospital admission using the mnemonic PANCREAS :
- Criteria Letter Clinical Parameter Threshold for 1 Point Allocated
- P PaO₂ < 8.0 kPa (60 mmHg) on room air
- A Age > 55 years
- N Neutrophils (WCC) > 15 × 10⁹/L
- C Calcium < 2.0 mmol/L (hypocalcaemia due to saponification)
- R Renal (Urea) > 16.0 mmol/L (reflects third-space fluid depletion)
- E Enzymes (LDH) > 600 U/L
- A Albumin < 32 g/L
- S Sugar (Glucose) > 10.0 mmol/L (in the absence of prior diabetes)
Important
Score Interpretation:
Glasgow Score ≥ 3: Predicts severe acute pancreatitis with substantial risk of multi-organ failure and infected pancreatic necrosis. Mandates immediate escalation to a High Dependency Unit (HDU) or Intensive Care Unit (ICU) .
Glasgow Score < 3: Mild pancreatitis managed on a general surgical or gastroenterology ward.
Acute Management Principles
Goal-Directed Fluid Resuscitation: Vigorous IV balanced crystalloids (Hartmann's solution), titrating to maintain a urine output >0.5 mL/kg/h and normalise haematocrit and lactate. Avoid excessive fluid overload.
Adequate Analgesia: Intravenous opioids (morphine or fentanyl) titrated to pain score.
Early Enteral Nutrition: Nil-by-mouth is outdated. Early oral feeding or enteral tube feeding (nasogastric or nasojejunal) commenced within 24 to 48 hours preserves the gut mucosal barrier, decreases bacterial translocation, and reduces septic complications compared to parenteral nutrition.
Prophylactic Antibiotics: Routine prophylactic intravenous antibiotics are not recommended for either mild or severe sterile pancreatitis; antibiotics are reserved only for proven infected pancreatic necrosis (guided by CT-guided fine needle aspiration) or systemic sepsis.
Gallstone Pancreatitis Management: In patients with concurrent cholangitis or persistent biliary obstruction, perform urgent ERCP with sphincterotomy within 72 hours . All patients with gallstone pancreatitis must undergo definitive cholecystectomy during the index admission (or within 2 weeks) to eliminate the high risk of recurrent, potentially fatal pancreatitis.
Liver Abscess
Pyogenic abscess: usually from biliary infection (cholangitis) or portal spread from bowel sepsis (appendicitis, diverticulitis); organisms include Klebsiella , E. coli and anaerobes. Fever, rigors and right upper quadrant pain with raised inflammatory markers; diagnose with ultrasound or CT and treat with percutaneous drainage plus IV antibiotics , looking for the source.
Amoebic abscess ( Entamoeba histolytica ): after travel to endemic areas, often without preceding dysentery; diagnosed with serology and imaging and treated with metronidazole followed by a luminal agent.